Daily Earnings

The day presented a mixed bag of earnings results and guidance.

Guidance and Results:

• Braze (BRZE) missed earnings expectations but revenue grew and beat estimates. Q1 and FY guidance were mixed.
• AAR Corp. (AIR) provided positive revenue guidance for the fourth quarter.
• MaxCyte (MXCT) issued negative revenue guidance for 2026.
• Other companies showed mixed guidance, with some like Paysign (PAYS), Spectral AI (MDAI), and Blaize (BZAI) seeing revenue above estimates.
• Several companies, including Hesai (HSAI), TELA Bio (TELA), Medtronic (MDT), KB Home (KBH), and Core & Main (CNM), gave revenue or earnings guidance below estimates.
• Concentrix (CNXC) gave Q2 guidance below estimates but reaffirmed for the full year.

Top Surprises:

• Positive Surprise: NRx Pharmaceuticals (NRXP) significantly beat consensus earnings estimates by 311.11%, reporting a profit instead of a loss, though revenue missed.
• Negative Surprise: Fennec Pharmaceuticals (FENC) significantly missed consensus earnings estimates by 466.67% and also missed revenue expectations.
• Negative Surprise: Braze (BRZE) missed earnings expectations by 33.33%.